Søren Echwald Morgenthaler

VP, Intellectual Property Rights at Samplix

Søren Echwald Morgenthaler provides expertise in patent strategy, freedom to operate analysis, and business strategy. He has listed one life sciences company and is or has been engaged with Anapa Biotech, Exiqon, and Novo Nordisk.

Location

Copenhagen, Denmark

Links


Org chart

No direct reports

Teams


Offices


Samplix

Samplix has developed a proprietary technology - the Xdrop™ technology – for single molecule sample preparation.